Navigation Links
HUYA Bioscience International Licenses Clinical Stage Anti-Arrhythmic Compound from the Shanghai Institute of Materia Medica
Date:10/1/2007

SAN DIEGO and SHANGHAI, China, Oct. 2 /PRNewswire/ -- HUYA Bioscience International (HUYA), a rapidly expanding biopharmaceutical company focused on the development of key disease-fighting drugs sourced from China, announced today that it has licensed a novel clinical stage anti-arrhythmic compound from the prestigious Shanghai Institute of Materia Medica (SIMM), Chinese Academy of Sciences.

The compound, HBI-3000 or sulcardine, exhibits a unique profile of myocardial ion channel regulation, compared to approved US and European anti- arrhythmic therapeutics. HBI-3000 has met significant Phase I safety milestones in three completed studies under a SIMM-sponsored Chinese IND. Gary T. Elliott, Pharm.D., Ph.D., Executive Vice President of Product Development at HUYA, commented that "the compound displays an ion channel selectivity profile that may contribute to effective treatment of both ventricular and atrial arrhythmias, while decreasing the risk of sudden death (Torsade de Pointes) associated with some anti-arrhythmics currently on the market."

Mireille Gingras, Ph.D., CEO of HUYA said, "There is a large unmet medical need for safer and more effective treatments for atrial and ventricular arrhythmia. We believe that HBI-3000 has the potential to fill this need, based on its unique properties and significant performance to date. By 2015, the global anti-arrhythmic market is expected to be $3.5 billion, and we feel we are on target to provide an innovative product."

Additional information is available at http://www.huyabio.com.

ABOUT HUYA

HUYA Bioscience International, LLC, with offices in San Diego and Shanghai, capitalizes on the explosive growth of the biotechnology and pharmaceutical industries in China. HUYA identifies and licenses promising Chinese pharmaceuticals for development and commercialization in Western markets. Using its management team and advisors, HUYA lowers the product development risk by accessing an extremely broad range of late stage preclinical and early clinical product opportunities and assisting with the generation of early clinical data in China. This information is highly valuable for risk mitigation, as well as the efficient initiation of clinical development in the United States and Europe. Further information about the company is available at http://www.huyabio.com.

ABOUT SIMM

The Shanghai Institute of Materia Medica (SIMM) at the Chinese Academy of Sciences emerged from the Institute of Materia Medica of the Peking Academy of Sciences, founded in 1932. It is currently located in the Zhang Jiang Hi-Tech Park, Pudong New District, Shanghai. SIMM's mission is to provide a comprehensive single-site solution to drug discovery and development. By combining basic and applied research in chemistry and biological disciplines, SIMM carries out modern drug discovery, as well as studies supporting identification of the purified ingredients responsible for the activity of traditional Chinese medicines. SIMM is also involved in the discovery of new therapeutic targets and carries out comprehensive pre-clinical evaluation of drug candidates, while also promoting commercialization; thereby playing a key role in building China's drug innovation capabilities.

For more information please contact:

HUYA Bioscience International, LLC

USA: Mireille Gingras, Ph.D. China: Wen Chen, M.S., M.B.A.

President and Chief Executive Officer Director Business Development

HUYA Bioscience International, LLC HUYA Bioscience International

(858) 798-8800 wchen@huyabio.com

mgingras@huyabio.com

Web site: http://www.huyabio.com

Media Contact:

Jonathan Zhu, Ph.D.

(858) 617-6273

jzhu@huyabio.com


'/>"/>
SOURCE HUYA Bioscience International, LLC
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Perscitus Biosciences secures $250K Commerce loan
2. Wisconsin biosciences rise to the challenge
3. Quintessence Biosciences advances cancer drug
4. Bioscience clusters: Too many or room for more?
5. Quintessence Biosciences names new president
6. Caden Biosciences may signal critical mass
7. Wisconsin start up Primorigen Biosciences corrals out-of-state investment
8. WARF signs licensing pact with BD Biosciences
9. Fisher Biosciences contracts with Madison-based GenTel BioSurfaces
10. Bioscience beats beer
11. State awards QRG Biosciences development grant
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/20/2017)... (PRWEB) , ... September 20, 2017 , ... ... organization focused on molecular manufacturing and other transformative technologies, announced the winners for ... Experiment and the other for Theory in nanotechnology/molecular manufacturing. , Established in 1993 ...
(Date:9/19/2017)... ... September 19, 2017 , ... ... fume hood and a high-performance fume hood. Along with the advantages and disadvantages ... for ductless vs. ducted hoods in the laboratory. , Attendees will learn from ...
(Date:9/19/2017)... (PRWEB) , ... September 19, 2017 , ... The new ... and time. The pocket testers even stand upright with a new cap design that ... or out in the field who need to test water quality. , The Oakton ...
(Date:9/19/2017)... Ann Arbor, MI (PRWEB) , ... September 19, ... ... chemical testing laboratory, is pleased to announce the recipients of its 2017 Science ... academic achievement, exceptional leadership qualities, and involvement with community service defray the costs ...
Breaking Biology Technology:
(Date:4/3/2017)... , April 3, 2017  Data ... precision engineering platform, detected a statistically significant ... product prior to treatment and objective response ... the potential to predict whether cancer patients ... to treatment, as well as to improve ...
(Date:3/28/2017)... 2017 The report "Video Surveillance ... Servers, Storage Devices), Software (Video Analytics, VMS), and Service ... Forecast to 2022", published by MarketsandMarkets, the market was ... projected to reach USD 75.64 Billion by 2022, at ... base year considered for the study is 2016 and ...
(Date:3/23/2017)... Research and Markets has announced the addition of the ... to 2025" report to their offering. ... The Global Vehicle Anti-Theft System Market ... the next decade to reach approximately $14.21 billion by 2025. ... for all the given segments on global as well as regional ...
Breaking Biology News(10 mins):